Caraco Digoxin Recalled by FDA - RECALL NEWS ALERT
Caraco Pharmaceutical Laboratories, a generic pharmaceutical company, announced today that all tablets of Caraco brand Digoxin, USP, 0.125 mg, and Digoxin, USP, 0.25 mg, distributed prior to March 31, 2009, which are not expired and are within the expiration date of September, 2011, are being voluntarily recalled to the consumer level. The tablets are being recalled because they may differ in size and therefore could have more or less of the active ingredient, digoxin. READ MORE: Caraco Digoxin Recall
Digitek Overdose - Digoxin Toxicity Death Lawsuits
DigitekŪ (Digoxin) is used to treat conditions such as congestive heart failure and atrial fibrillation/atrial flutter (types of fast heartbeats). Digoxin helps the heart to beat more strongly and regularly. However double the prescribed amount of digoxin, the active ingredient in Digitek can cause a risk of digitalis toxicity in patients. Even a single Digitek overdosage can be fatal and can cause digoxin toxicity. Those Digitek users suffering from renal failure are at risk even a higher risk of digitalis toxicity because they cannot excrete digitalis from their bodies like healthy people.
Talk to a Lawyer. Get a Free Digitek Lawsuit Evaluation
Digitek, Bertek & UDL Digoxin Recalled by FDA
Morristown, NJ -- April 25, 2008 -- Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, is initiating a Class I nationwide recall of DigitekŪ (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. (See:FDA Recall of Digitek.)
The voluntary "all lots" recall is due to the possibility that tablets with double the appropriate thickness may have been commercially released. These tablets were slightly thicker due to an extra coating and may contain two times the approved level of active ingredient than it appropriate.
DigitekŪ is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can also result from excessive Digitalis intake. FDA has received many reports of serious illnesses and injuries regarding digitalis toxicity. (See:Digitek Overdose Side Effects)
Digitek Lawsuit News Update
Digoxin Injury & Digitek Wrongful Death Lawsuit - Contact a Digitek Lawyer
If you or a loved one have been seriously injured or a loved one has died as a result of digitalis toxicity or an overdose of Digitek, Bertek brand Digoxin and/or UDL Digoxin, please contact immediately for a Free Digitek Lawsuit Evaluation or call us at 1-800-883-9858.
Nationwide Help is Available
